KCNN1 and atrial fibrillation: KCNN1 is expressed in human and murine heart with atrial predominance (Tuteja et al., 2005; Xu et al., 2003), indicating a potential advantage for KCa2.1 channels as atrial‐selective targets in AF therapy (Hancox et al., 2016).